In contrast, Yang et al., describe that inhibition of DPP4 accelerates breast cancer metastasis through induction of the CXCL12/CXCR4, which activates mammalian-target-of-rapamycin (mTOR) to induce EMT [135]. The gene discussed is CXCR4; the disease is breast carcinoma.